How Chronic Kidney Disease in Type 2 Diabetes Contributes to Cardiovascular Disease
CKD in patients with T2D represents a major public health problem, resulting in significant cardiovascular and kidney adverse outcomes in the United States and worldwide.
Date: Tuesday, March 16, 2021
Time: 4:00 pm – 5:00 pm ET
Join Know Diabetes by Heart, American Kidney Fund and National Kidney Foundation, as experts Peter A. McCullough, MD, MPH Professor of Medicine, Vice Chief of Internal Medicine, Baylor University Medical Center, Orlando Gutierrez, MD Professor of Medicine and head of the Section of Epidemiology and Outcomes Research in the Division of Nephrology at the University of Alabama at Birmingham and Joseph A. Vassalotti, MD Chief Medical Officer of the National Kidney Foundation (NKF) and Associate Clinical Professor of Medicine in the Division of Nephrology, at Icahn School of Medicine at Mount Sinai as they discuss:
- Understanding the epidemiology of diabetes, CVD and CKD
- Identifying and managing renal complications in patients with T2D and CVD
- Summarizing new therapies to manage cardiovascular and renal risk in patients with T2D